Istent Inject Trabecular Micro-Bypass System
Payments companies reported to CMS as associated with Istent Inject Trabecular Micro-Bypass System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Istent Inject Trabecular Micro-Bypass System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Istent Inject Trabecular Micro-Bypass System
These are the largest totals companies reported as associated with Istent Inject Trabecular Micro-Bypass System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steven Sarkisian | Oklahoma City, OK | Glaucoma Specialist | $5,874.53 |
| David Slade | St George, UT | Ophthalmology | $5,447.21 |
| Alison Granier | Coeur D Alene, ID | Ophthalmology | $688.40 |
| David Dance | Coeur D Alene, ID | Ophthalmology | $688.40 |
| John Berdahl | Sioux Falls, SD | Ophthalmology | $396.32 |
| Savak Teymoorian | Laguna Hills, CA | Ophthalmology | $368.40 |
| Leon Herndon | Durham, NC | Ophthalmology | $368.40 |
| Inder Singh | Racine, WI | Ophthalmology | $368.40 |
| Richard Lindstrom | Bloomington, MN | Ophthalmology | $368.20 |
| Patricia Gelner | Chesterfield, MO | Optometrist | $276.10 |
Prescribed Istent Inject Trabecular Micro-Bypass System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.